The pharmacokinetics of S-warfarin in healthy subjects carrying different CYP2C9 genotypes.

被引：0
|
作者：
Shaoul, H. [1 ]
Blotnick, S. [1 ]
Muszkat, M. [1 ]
Caraco, Y. [1 ]
机构：
[1] Hadassah Univ Hosp, Jerusalem, Israel
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes
    Niemi, M
    Cascorbi, I
    Timm, R
    Kroemer, HK
    Neuvonen, PJ
    Kivistö, KT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 326 - 332
  • [2] Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects
    Shaul, Chanan
    Blotnick, Simcha
    Muszkat, Mordechai
    Bialer, Meir
    Caraco, Yoseph
    MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (01) : 75 - 83
  • [3] Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects
    Chanan Shaul
    Simcha Blotnick
    Mordechai Muszkat
    Meir Bialer
    Yoseph Caraco
    Molecular Diagnosis & Therapy, 2017, 21 : 75 - 83
  • [4] Metabolism of warfarin enantiomers in Japanese patients with different CYP2C9/2C19 genotypes.
    Takahashi, H
    Kubota, T
    Kimura, S
    Echizen, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 148 - 148
  • [5] Pharmacokinetics of glibenclamide and glimepiride in Finnish subjects with different CYP2C9 genotypes
    Timm, R
    Niemi, M
    Neuvonen, P
    Kroemer, HK
    Cascorbi, I
    Kivistö, KT
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S98 - S98
  • [6] CYP2C9 Genotype-DependentWarfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R-and S-Warfarin and Their Oxidative Metabolites
    Flora, Darcy R.
    Rettie, Allan E.
    Brundage, Richard C.
    Tracy, Timothy S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (03): : 382 - 393
  • [7] Hydroxywarfarin Metabolites Potently Inhibit CYP2C9 Metabolism of S-Warfarin
    Jones, Drew R.
    Kim, So-Young
    Guderyon, Michael
    Yun, Chul-Ho
    Moran, Jeffery H.
    Miller, Grover P.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2010, 23 (05) : 939 - 945
  • [8] Prediction of the oral clearance of S-warfarin in CYP2C9 genotypes from in vitro enzyme kinetic data
    Almond, Lisa M.
    Rowland-Yeo, Karen
    Howgate, Eleanor M.
    Tucker, Geoff T.
    Rostami-Hodjegan, A.
    DRUG METABOLISM REVIEWS, 2006, 38 : 92 - 93
  • [9] R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9
    Yong, Wei Peng
    Kim, Tae Won
    Undevia, Samir D.
    Innocenti, Federico
    Ratain, Mark J.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (11) : 1904 - 1908
  • [10] CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians
    Vianna-Jorge, R
    Perini, JA
    Rondinelli, E
    Suarez-Kurtz, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) : 18 - 26
12345